CAS: 193527-91-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | IPAG REF: IN-DA00AOP6CAS: 193527-91-2 | 98% | To inquire | Wed 27 Nov 24 |
 | IPAG REF: 3D-THA52791CAS: 193527-91-2 | Min. 95% | To inquire | Wed 08 Jan 25 |
 | IPAG REF: TM-T22870CAS: 193527-91-2 | 98.8% | 37.00 €~647.00 € | Wed 15 Jan 25 |
Ref: IN-DA00AOP6
| 5mg | 283.00 € | ||
| 10mg | 559.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 27 Nov 2024
IPAG
CAS:193527-91-2
IPAG is a medicinal compound that has been shown to have potent anticancer properties. It …
Formula:
C17H22IN3
Purity:
Min. 95%
Molecular weight:
395.28 g/mol
Ref: 3D-THA52791
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
IPAG
CAS:193527-91-2
IPAG is a potent σ-receptor antagonist (pKi=4.3). IPAG can induce cell apoptosis.
Formula:
C17H22IN3
Purity:
98.8%
Color and Shape:
Solid
Molecular weight:
395.28
Ref: TM-T22870
| 1mg | 45.00 € | ||
| 2mg | 37.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 135.00 € | ||
| 25mg | 261.00 € | ||
| 50mg | 449.00 € | ||
| 100mg | 647.00 € | ||
| 200mg | 544.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
